Vaxcyte: evp/coo Wassil Jim exercised 2,250 shares

What happened

• Wassil Jim, evp and chief scientific officer and chief operating officer, exercised 2,250 options at $5.35 on Oct 1, 2026, for $12,038 and disposed of 2,250 shares the same day in two open-market sales for total proceeds of $127,513 (2,155 shares at a weighted-average $56.65 for $122,089; 95 shares at a weighted-average $57.09 for $5,424).

Key details

• Transaction date: Oct 1, 2026.
• Exercise (code M): 2,250 shares acquired at $5.35, cash paid $12,038.
• Sales (code S): 2,155 shares at weighted-average $56.65 (shares sold at prices ranging from $56.065 to $56.955) and 95 shares at weighted-average $57.09 (shares sold at prices ranging from $57.09 to $57.10). Total sale proceeds $127,513.
• Shares owned after the transaction: not stated in the information provided in this summary.
• Footnotes from the filing:
  • F1: sales were effected pursuant to a Rule 10b5-1 trading plan adopted Dec 9, 2025.
  • F2/F3: reported prices are weighted averages; the filing gives price ranges and says the reporting person will provide per-price breakdowns on request.
  • F4: the stock option is fully vested and exercisable.

Why it may matter

• The filing shows an option exercise followed by immediate sales of the exercised shares, consistent with a cashless exercise (exercised shares were sold the same day).
• The filing does not show why the insider traded or why the company acted.